Prostate cancer immunotherapy trial halted early: what we know
NCT ID NCT05617040
First seen Nov 10, 2025 · Last updated May 16, 2026 · Updated 26 times
Summary
This early-stage trial tested an experimental immunotherapy called VTP-850 in 22 men whose prostate cancer had returned after initial treatment like surgery or radiation. The goal was to check safety and see if the treatment could lower PSA levels, a marker of cancer activity. The study was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Carolina Urologic Research Center
Myrtle Beach, South Carolina, 29572, United States
-
Columbia University Irving Medical Center
New York, New York, 10032, United States
-
Cornell University
New York, New York, 10065-4805, United States
-
Fox Chase Cancer Center
Philadelphia, Pennsylvania, 19111, United States
-
Fred Hutchinson Cancer Center
Seattle, Washington, 98109, United States
-
University of Virginia Health System
Charlottesville, Virginia, 22908, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.